Spots Global Cancer Trial Database for A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study
Official Title: A 12 Month, Long-term Follow-up Study of Patients With Actinic Keratosis on Non-head Areas (Trunk and Extremities) Who Have Completed Day 57 in Study PEP005-020
Study ID: NCT00952783
Conditions
Interventions
Study Description
Brief Summary: This study is designed to follow up patients, who have achieved complete clearance of AK lesions (lesion count of 0) at Day 57 in the PEP005-020 study, over a 12 month period to assess both recurrence of Actinic Keratosis (AK) lesions and long term safety in the selected treatment area.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Park Avenue Dermatology, Orange Park, Florida, United States
Medaphase Inc, Newnan, Georgia, United States
Gwinnett Clinical Research Centre, Snellville, Georgia, United States
Michigan Center for Research Corp, Clinton Twp, Michigan, United States
Henry Ford Health Systems, Detroit, Michigan, United States
Dermatology Associates of Rochester, Rochester, New York, United States
Oregon Health and Science University, Portland, Oregon, United States
Dermatology Research Associates, Nashville, Tennessee, United States
Dematology on Ward, Adelaide, South Australia, Australia
Dermatology Institute of Victoria, Melbourne, Victoria, Australia
St John of God Dermatology, Subiaco, Western Australia, Australia
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
